Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021.

Martins AC, Oshiro MY, Albericio F, de la Torre BG, Pereira GJV, Gonzaga RV

Open source

DOI
10.3390/biomedicines10092325
Published
2022 Sep 19
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines10092325,
  title = {Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021.},
  author = {Martins AC and Oshiro MY and Albericio F and de la Torre BG and Pereira GJV and Gonzaga RV},
  year = {2022},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines10092325},
  url = {https://doi.org/10.3390/biomedicines10092325}
}

RIS

TY  - JOUR
TI  - Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021.
AU  - Martins AC
AU  - Oshiro MY
AU  - Albericio F
AU  - de la Torre BG
AU  - Pereira GJV
AU  - Gonzaga RV
PY  - 2022
JO  - Biomedicines
DO  - 10.3390/biomedicines10092325
UR  - https://doi.org/10.3390/biomedicines10092325
ER  - 

APA

AC, M., MY, O., F, A., BG, D. L. T., GJV, P., & RV, G. (2022). Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021.. Biomedicines. https://doi.org/10.3390/biomedicines10092325

Source records